FINANCIAL STATEMENT ANALYSIS

USED BY US DEPARTMEN OF EDUCATION, UNIVERSITIES, STUDENTS & ACCOUNTING PRO'S

VentureLine tracks and provides 5-year financial statement analysis on approximately 7,000+ publicly traded companies; the SEC-traceable data is updated weekly. For your convenience you can access that current company financial statement analysis information by clicking directly on the Company Name, visit their Website or enter the Company name or Ticker symbol, e.g. enter 'Microsoft' or 'MSFT' for Microsoft, in the Company Search window below.

FINANCIAL STATEMENT ANALYSIS UPDATED: JULY 24, 2022

Results 51 through 100 of 143

PHARMACEUTICAL PREPARATIONS - SIC # 2834

Ticker Exchange Company Financial Reports SIC #
GLPG Nasdaq Galapagos NV 2834
GRCE Nasdaq Grace Therapeutics, Inc. 2834
GRI Nasdaq GRI Bio, Inc. 2834
HCM Nasdaq HUTCHMED (China) Limited 2834
HLVX Nasdaq HilleVax, Inc. 2834
HROW Nasdaq Harrow, Inc. 2834
IBIO Nasdaq iBio, Inc. 2834
IDYA Nasdaq IDEAYA Biosciences, Inc. 2834
IMA Nasdaq ImageneBio, Inc. 2834
IMRN Nasdaq Immuron Limited 2834
INBX Nasdaq Inhibrx Biosciences, Inc. 2834
INCY Nasdaq Incyte Corporation 2834
INKT Nasdaq MiNK Therapeutics, Inc. 2834
INNPD Over the counter InnoCan Pharma Corporation 2834
IOBT Nasdaq IO Biotech, Inc. 2834
ITRM Nasdaq Iterum Therapeutics plc 2834
IVA Nasdaq Inventiva S.A. 2834
JAZZ Nasdaq Jazz Pharmaceuticals plc 2834
KALV Nasdaq KalVista Pharmaceuticals, Inc. 2834
KAPA NYSE American Kairos Pharma, Ltd. 2834
KLTO Nasdaq Klotho Neurosciences, Inc. 2834
KPRX Nasdaq Kiora Pharmaceuticals, Inc. 2834
KZIA Nasdaq Kazia Therapeutics Limited 2834
LEXX Nasdaq Lexaria Bioscience Corp. 2834
LGND Nasdaq Ligand Pharmaceuticals Incorporated 2834
LPTX Nasdaq Leap Therapeutics, Inc. 2834
MAIA NYSE American MAIA Biotechnology, Inc. 2834
MBRX Nasdaq Moleculin Biotech, Inc. 2834
MIRM Nasdaq Mirum Pharmaceuticals, Inc. 2834
MRK New York Merck & Co., Inc. 2834
MTSR Nasdaq Metsera, Inc. 2834
MURA Nasdaq Mural Oncology plc 2834
NKTR Nasdaq Nektar Therapeutics 2834
NKTX Nasdaq Nkarta, Inc. 2834
NRIX Nasdaq Nurix Therapeutics, Inc. 2834
NRXP Nasdaq NRx Pharmaceuticals, Inc. 2834
NSRX NYSE American Nasus Pharma Ltd. 2834
NTHI Nasdaq NeOnc Technologies Holdings, Inc. 2834
NTLA Nasdaq Intellia Therapeutics, Inc. 2834
NVAX Nasdaq Novavax, Inc. 2834
NVS New York Novartis AG 2834
OCGN Nasdaq Ocugen, Inc. 2834
OCUL Nasdaq Ocular Therapeutix, Inc. 2834
OMER Nasdaq Omeros Corporation 2834
ORGO Nasdaq Organogenesis Holdings Inc. 2834
ORXOY Over the counter Orexo AB (publ) 2834
OTLK Nasdaq Outlook Therapeutics, Inc. 2834
PCSA Nasdaq Processa Pharmaceuticals, Inc. 2834
PEPG Nasdaq PepGen Inc. 2834
PFE New York Pfizer Inc. 2834
Results 50 through 100 of 143